Corvus Pharmaceuticals Inc (FRA:C17)
€ 9 0.89 (10.97%) Market Cap: 558.13 Mil Enterprise Value: 514.69 Mil PE Ratio: 0 PB Ratio: 11.67 GF Score: 20/100

Q4 2021 Corvus Pharmaceuticals Inc Earnings Call Transcript

Mar 10, 2022 / 09:30PM GMT
Operator

Greetings. Welcome to Corvus Pharmaceuticals' Fourth Quarter 2021 Earnings Conference Call. (Operator Instructions) Please note, this conference is being recorded.

I will now turn the conference over to Zack Kubow of Real Chemistry. Thank you. You may begin.

Zack Kubow
Real Chemistry - Group Director

Thank you, operator, and good afternoon, everyone. Thanks for joining us for the Corvus Pharmaceuticals Fourth Quarter 2021 Business Update and Financial Results Conference Call.

On the call to discuss the results and business updates are Richard Miller, Chief Executive Officer; and Leiv Lea, Chief Financial Officer. The executive team will open the call with some prepared remarks followed by a question-and-answer period.

I would like to remind everyone that comments made by management today and answers to questions will include forward-looking statements. Forward-looking statements are based on estimates and assumptions as of today, and are subject to risks and uncertainties that may cause actual results to differ materially from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot